治疗非胰岛素依赖型糖尿病。口服药物还是胰岛素？
Treating non-insulin-dependent diabetes. Oral agents or insulin?
作者信息
Shlossberg A H
机构信息
Division of Endocrinology, Dalhousie University, Halifax.
出版信息
Can Fam Physician. 1993 Jan;39:119-20, 123-6.
Abstract
This article describes suggested treatment regimens for non-insulin-dependent diabetes mellitus. Diet is usually the first-line therapy. If this fails, most patients should be given a trial of oral agents, usually sulfonylurea first. Sulfonylurea and metformin can be combined if necessary. If oral agents fail, insulin is indicated. Insulin and an oral agent sometimes are used together.
摘要
本文介绍了非胰岛素依赖型糖尿病的推荐治疗方案。饮食通常是一线治疗方法。如果饮食治疗失败，大多数患者应尝试口服药物治疗，通常首先使用磺脲类药物。必要时，磺脲类药物和二甲双胍可以联合使用。如果口服药物治疗失败，则需使用胰岛素。胰岛素和口服药物有时也会联合使用。
相似文献
1
Treating non-insulin-dependent diabetes. Oral agents or insulin?治疗非胰岛素依赖型糖尿病。口服药物还是胰岛素？
Can Fam Physician. 1993 Jan;39:119-20, 123-6.
2
Non-insulin-dependent (type II) diabetes mellitus.非胰岛素依赖型（II型）糖尿病
CMAJ. 1991 Dec 15;145(12):1571-81.
3
4
The management of non-insulin-dependent diabetes mellitus in the elderly.老年非胰岛素依赖型糖尿病的管理
J Fam Pract. 1993 Mar;36(3):329-35.
5
6
[Treatment of non-insulin dependent diabetes (type 2 diabetes mellitus)].
Tidsskr Nor Laegeforen. 1992 Mar 10;112(7):912-4.
7
Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.胰岛素与磺脲类药物联合治疗II型糖尿病的疗效：随机安慰剂对照试验的荟萃分析
Arch Intern Med. 1996 Feb 12;156(3):259-64.
8
[Rational therapy of Type II diabetes].
Ther Umsch. 1996 Dec;53(12):914-24.
9
[Insulin in the balance].
Ned Tijdschr Geneeskd. 1988 Jul 30;132(31):1417-8.
10
Promising new approaches.有前景的新方法。
Diabetes Obes Metab. 1999 May;1 Suppl 1:S41-8.
引用本文的文献
1
Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.二甲双胍。其药理特性及在非胰岛素依赖型糖尿病治疗中的应用综述。
Drugs. 1995 May;49(5):721-49. doi: 10.2165/00003495-199549050-00007.
本文引用的文献
1
Hypoglycemic therapy in patients diagnosed to have diabetes at 30 years of age or older.
J Chronic Dis. 1984;37(3):159-65. doi: 10.1016/0021-9681(84)90143-7.
2
Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.
Ann Intern Med. 1988 Mar;108(3):334-40. doi: 10.7326/0003-4819-108-3-334.
3
Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view.欧洲非胰岛素依赖型糖尿病的管理：共识观点
Diabet Med. 1988 Apr;5(3):275-81. doi: 10.1111/j.1464-5491.1988.tb00984.x.
4
Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.
Diabetes Care. 1989 Sep;12(8):537-43. doi: 10.2337/diacare.12.8.537.
5
Intensive insulin therapy for treatment of type I diabetes.
Diabetes Care. 1990 Dec;13(12):1265-83. doi: 10.2337/diacare.13.12.1265.
6
Insulin use in NIDDM.
Diabetes Care. 1990 Dec;13(12):1240-64. doi: 10.2337/diacare.13.12.1240.
7
Devices for insulin administration.
Diabetes Care. 1990 Sep;13(9):955-79. doi: 10.2337/diacare.13.9.955.
8
Insulin use in NIDDM. Rationale based on pathophysiology of disease.
Diabetes Care. 1990 Sep;13(9):1011-20. doi: 10.2337/diacare.13.9.1011.
9
Biguanides and sulfonylureas as combination therapy in NIDDM.
Diabetes Care. 1990 Aug;13 Suppl 3:37-41. doi: 10.2337/diacare.13.3.37.
10
Sulfonylureas. Why, which, and how?磺脲类药物。为何使用、使用哪种以及如何使用？
Diabetes Care. 1990 Aug;13 Suppl 3:18-25. doi: 10.2337/diacare.13.3.18.
Zotero 插件